Chariot AI: $6,643 MRR from an AI website builder, per payment data on TrustMRR
TrustMRR pulls this revenue from Stripe. Chariot AI is an AI website builder for small businesses and non-technical users.
Subject: Chariot AISubscription ($17 per month)
Case Overview & Background
Chariot AI and is an AI website builder for small businesses and non-technical users. The listing gives a founding date of 2025-05-03. TrustMRR shows $6,588 in the last 30 days, $6,643 MRR, $100,436 all-time revenue, 306 active subscriptions as of November 2, 2026.
How AI Is Used
Step-by-Step Process
The business focuses on one outcome: an AI website builder for small businesses and non-technical users.
Pricing on the listing: $17/mo.
Revenue is shared publicly through a Stripe connection on TrustMRR.
Customer Acquisition & Distribution
Limitations, Risks & Failure Modes
What may not apply to you, and what could go wrong:
- Revenue is not profit; AI model, hosting and marketing costs are not shown
- Figures change daily; this is a snapshot from November 2, 2026
- Products built on third-party AI models depend on those providers' pricing and policies
Key Takeaways
- A narrow AI product or service with a clear outcome can be sold directly to consumers or businesses
- Payment-provider-verified figures are stronger than screenshots but are still not an audit
Sources
TrustMRR verified revenue page: Chariot AI
Note: Revenue pulled from Stripe. Viewed November 2, 2026. Product description on the page is written by the founder.
Category page banner: Reach readers researching one specific AI business model.
One clearly labelled banner on a category page such as Micro-SaaS or AI Agencies, shown next to the documented cases your product is relevant to.
Sponsored placements are always labelled and never change how cases are researched, labelled, or ranked.
Commercial disclosure: We currently have no affiliate or sponsorship relationship with any tool or person on this page. If that changes, affiliate links and sponsored content will be clearly labelled, and evidence labels will never be changed for commercial reasons.
